About TD2
TD2 is a company based in Phoenix (United States) founded in 2003 was acquired by RCT in June 2020.. The company has 119 employees as of December 31, 2021. TD2 offers products and services including Clinical Trial Services, Preclinical Services, Regulatory Support, and Flow Cytometry Services. TD2 operates in a competitive market with competitors including GSK, Avidity Biosciences, Vividion Therapeutics, Korro Bio and Sutro Biopharma, among others.
- Headquarter Phoenix, United States
- Employees 119 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Translational Drug Development, Llc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
119
as on Dec 31, 2021
-
Acquired by
RCT
(Jun 04, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of TD2
TD2 offers a comprehensive portfolio of products and services, including Clinical Trial Services, Preclinical Services, Regulatory Support, and Flow Cytometry Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Design and execution of oncology clinical trials
Development of cancer models and bioanalytical services
Assistance with IND filings and FDA interactions
Analysis of drug effects on immune cells
Unlock access to complete
Funding Insights of TD2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in TD2
TD2 has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Research Corporation Technologies. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Research Corporation Technologies is engaged in licensing biomedical technologies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by TD2
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - TD2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Td2 Comparisons
Competitors of TD2
TD2 operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Vividion Therapeutics, Korro Bio and Sutro Biopharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
RNA-editing technologies are provided for precision medicine applications.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Therapeutics for rare respiratory diseases are developed by Savara Pharma.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Td2
Frequently Asked Questions about TD2
When was TD2 founded?
TD2 was founded in 2003.
Where is TD2 located?
TD2 is headquartered in Phoenix, United States. It is registered at Phoenix, Arizona, United States.
How many employees does TD2 have?
As of Dec 31, 2021, the latest employee count at TD2 is 119.
What does TD2 do?
Translational Drug Development (TD2), a wholly owned subsidiary of the Translational Genomics Research Institute (TGen) is an oncology drug development organization that provides services for oncology-focused biopharmaceutical companies. It provides pre-clinical services like in vitro myeloma screening tools, in vivo imaging capabilities, image-guided micro-irradiation labs, and specialized tumor models. Besides, it offers bioanalysis and DMPK facilities. Additionally, it also offers regulatory and clinical services like FDA regulations, pre-Investigational New Drug (IND) application and IND strategies, IND submissions, FDA-regulated trials, Good Laboratory Practices (GLP); ToxicologyPharmacology Support Services.
Who are the top competitors of TD2?
TD2's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
What products or services does TD2 offer?
TD2 offers Clinical Trial Services, Preclinical Services, Regulatory Support, and Flow Cytometry Services.
Who are TD2's investors?
TD2 has 1 investor. Key investors include Research Corporation Technologies.